Integer (ITGR) to Release Quarterly Earnings on Thursday

Integer (NYSE:ITGR - Get Free Report) is anticipated to post its Q2 2025 quarterly earnings results before the market opens on Thursday, July 24th. Analysts expect Integer to post earnings of $1.57 per share and revenue of $464.37 million for the quarter. Integer has set its FY 2025 guidance at 6.150-6.510 EPS.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million for the quarter, compared to analysts' expectations of $428.51 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. The firm's revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.14 earnings per share. On average, analysts expect Integer to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Integer Price Performance

ITGR traded down $2.13 during trading on Friday, reaching $112.51. The stock had a trading volume of 463,003 shares, compared to its average volume of 390,078. The stock has a market cap of $3.93 billion, a PE ratio of 53.32, a PEG ratio of 0.97 and a beta of 0.98. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40. Integer has a one year low of $104.93 and a one year high of $146.36. The business has a 50-day moving average of $119.65 and a 200-day moving average of $124.39.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ITGR shares. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and upped their price target for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. KeyCorp dropped their target price on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Raymond James Financial increased their target price on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Finally, Benchmark dropped their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a report on Friday, April 25th. Two investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Integer currently has a consensus rating of "Moderate Buy" and a consensus price target of $146.25.

Insider Transactions at Integer

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the sale, the chief executive officer directly owned 47,000 shares in the company, valued at $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Martin C. Maxwell sold 8,720 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. The trade was a 28.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold 362,434 shares of company stock worth $44,577,115 over the last quarter. 2.16% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Integer

A number of institutional investors have recently added to or reduced their stakes in the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Integer by 4.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider's stock valued at $12,900,000 after buying an additional 4,873 shares in the last quarter. United Services Automobile Association bought a new position in shares of Integer during the 1st quarter valued at approximately $258,000. Jones Financial Companies Lllp boosted its position in shares of Integer by 79,888.9% during the 1st quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider's stock valued at $850,000 after acquiring an additional 7,190 shares during the last quarter. Millennium Management LLC boosted its position in shares of Integer by 2,408.8% during the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider's stock valued at $14,531,000 after acquiring an additional 118,224 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Integer by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider's stock valued at $2,539,000 after acquiring an additional 837 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.